Orexigen Therapeutics (OREX) Tops Q3 EPS by 22c
Tweet
Share
E-mailGet Alerts OREX Hot Sheet
Price: $0.22 --0%
Financial Fact:
Research and development: 5.25M
Today's EPS Names:
SCWO, HSAI, SYRS, More
Financial Fact:
Research and development: 5.25M
Today's EPS Names:
SCWO, HSAI, SYRS, More
Join SI Premium – FREE
Orexigen Therapeutics (NASDAQ: OREX) reported Q3 EPS of $0.09, $0.22 better than the analyst estimate of ($0.13). Revenue for the quarter came in at $30.9 million versus the consensus estimate of $8.93 million.
For earnings history and earnings-related data on Orexigen Therapeutics (OREX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Klarna shares tumble on weak full-year revenue guidance
- Prenetics Global (PRE) Tops Q2 EPS by 18c
- Benchmark Reiterates Speculative Buy Rating on Nephros (NEPH) Following Strong Q2 Results
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
